Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.605
-0.070 (-4.18%)
Apr 24, 2026, 5:01 PM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 73.32 million as of April 24, 2026. Its market cap has decreased by -5.16% in one year.
Market Cap
73.32M
Enterprise Value
57.42M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.61
Market Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 73.32M, a decrease of -49.22%. That is a compound annual growth rate of -13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 73.32M | -15.43% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | 144.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 120.67M |
| Annexin Pharmaceuticals AB | 106.59M |
| Scandinavian ChemoTech AB | 104.62M |
| Biovica International AB | 95.16M |
| Magle Chemoswed Holding AB | 94.99M |
| Alzinova AB | 89.41M |
| OncoZenge AB | 82.74M |
| Spago Nanomedical AB | 79.06M |